The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to
the Securities and Exchange Commission (SEC)
by insider Ellis P Ron since year 2005.
The trader's CIK number is 1509418.
At the time of this reporting, Ellis P Ron is the President and CEO of Endocyte Inc .
(stock ticker symbol ECYT).
See this page for all insider trading activities at Endocyte Inc .
| Trade Date | Symbol | Company Name (Issuer) | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|---|
| 2015-02-06 | ECYT | Endocyte Inc | Option Ex | 52,356 | 5.21 | 272,774 |
| 2014-11-05 | ECYT | Endocyte Inc | Option Ex | 19,060 | 1.91 | 36,404 |
| 2014-03-10 | ECYT | Endocyte Inc | Option Ex | 80,000 | 1.91 | 152,800 |
| 2013-12-02 | ECYT | Endocyte Inc | Sale | 3,000 | 12.00 | 36,000 |
| 2013-12-04 | ECYT | Endocyte Inc | Option Ex | 3,000 | 1.91 | 5,730 |
| 2013-11-06 | ECYT | Endocyte Inc | Sale | 3,000 | 12.00 | 36,000 |
| 2013-11-07 | ECYT | Endocyte Inc | Option Ex | 3,000 | 1.91 | 5,730 |
| 2013-10-02 | ECYT | Endocyte Inc | Option Ex | 3,000 | 1.91 | 5,730 |
| 2013-10-01 | ECYT | Endocyte Inc | Sale | 3,000 | 13.30 | 39,900 |
| 2013-09-04 | ECYT | Endocyte Inc | Option Ex | 3,000 | 1.91 | 5,730 |
| 2013-09-03 | ECYT | Endocyte Inc | Sale | 3,000 | 14.54 | 43,620 |
| 2013-08-02 | ECYT | Endocyte Inc | Option Ex | 3,000 | 1.91 | 5,730 |
| 2013-08-01 | ECYT | Endocyte Inc | Sale | 3,000 | 18.12 | 54,360 |
| 2013-07-16 | ECYT | Endocyte Inc | Option Ex | 3,000 | 1.91 | 5,730 |
| 2013-07-15 | ECYT | Endocyte Inc | Sale | 3,000 | 17.01 | 51,030 |
| 2013-05-01 | ECYT | Endocyte Inc | Sale | 500 | 13.88 | 6,940 |
| 2013-04-01 | ECYT | Endocyte Inc | Sale | 500 | 12.54 | 6,270 |
| 2013-03-27 | ECYT | Endocyte Inc | Sale | 1,500 | 12.00 | 18,000 |
| 2012-12-31 | ECYT | Endocyte Inc | Sale | 6,000 | 8.75 | 52,500 |
| 2011-12-16 | ECYT | Endocyte Inc | Option Ex | 21,998 | 1.36 | 30,027 |
| 2011-08-05 | ECYT | Endocyte Inc | Option Ex | 14 | .19 | 2 |
| 2011-02-04 | ECYT | Endocyte Inc | Buy | 2,500 | 6.00 | 15,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ellis P Ron (President and CEO of Endocyte Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.